With an analysis limited to those who stayed in the study, rimonabant resulted in an average weight loss of about 19 pounds, Dr. Pi-Sunyer said. In comparison, patients who received a placebo and who, like the rimonabant patients, were given a diet and consultations with a dietician, lost about 5 pounds in a year.
Patients hit plateaus after about 34 weeks, when their weight loss ceased. If they stopped taking the drug, they gained back all they had lost, but the hope is that if people continue taking the drug indefinitely, they can maintain that weight loss and gain health benefits, Dr. Pi-Sunyer said.
For 14 pounds, you'd take a drug for the rest of your life? And I suppose you'd want the government/insurance companies to pay for it? Because obesity is an illness, right?
:.
0 comments:
Post a Comment